Coforge_logo_Coral_White-2

Panel Discussion on

AI in Life Sciences: Reimagining Validation & Compliance

18th November, 2025
9:00 AM PST/ 12:00 PM EST/ 6:00 PM (CEST)/ 10:30 PM IST
Virtual

Digital enabled Validation & Compliance: From Documents to Decisions

In the highly regulated world of life sciences, compliance is not just a regulatory mandate; it’s a direct link to patient safety, drug quality, and organizational trust - it’s a lifeline. For decades, pharmaceutical companies have relied on traditional Computer System Validation (CSV) to demonstrate regulatory compliance with FDA 21 CFR Part 11, EU Annex 11, and GxP requirements.

 

However, as regulations evolve and digital portfolios expand, traditional CSV and compliance monitoring will be replaced with more risk-based approaches supported by continuous audit readiness frameworks.

 

Join our expert panel to hear their views and journey of AI infused Validation & Compliance Monitoring. The session will focus on the latest regulatory policies, AI approaches, and Tools/ Accelerators adopted by Industry for Automated Validation & Compliance.

Speakers

Sachin Bhandari

Sachin Bhandari

Head of Quality Digital Industrialization
UCB

Aji-Karunana (1)

Carolyn Troiano

Founder, FDA Compliance Advisor
Brainstorm Central Consulting

Aji-Karunana

Aji Karunan

Vice President, Asia Pacific
Valgenesis

Munish-Sharma

Munish Sharma

Head of Computer Systems Validation
Arcolab

Kelli L. Bravo

Kelli L. Bravo

Vice President, Healthcare and Life Sciences
Coforge

Key Takeaways

 

  • Insights from Industry Experts on the latest trends and policies impacting Validation & Compliance
  • How are Pharmaceutical, Biotechnology, Medical Device organizations planning this journey?
  • AI / Automation journey and roadmap, while addressing organization, cultural and governance challenges / considerations

Reserve Your Spot